Delivery Order SPE2DB25D9305-SPE2DB26FQAAQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $34,224.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL syringes. The award was issued on October 27, 2025, with an ultimate completion date of November 18, 2025, and carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency awarded a delivery order valued at $5,027.08 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 mL vials. This firm fixed-price delivery order, issued on November 5, 2025, with completion targeted by November 28, 2025, carries no set-aside designation, indicating the award was made through open competition. The order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $10,110 to DMS Pharmaceutical Group Inc. for EYLEA HD 8 mg/0.07 ml vials on November 6, 2025, with an ultimate completion date of December 1, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. This...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $5,027.08 to DMS Pharmaceutical Group Inc. for EYLEA 2 mg/0.05 mL vials on October 29, 2025, with completion scheduled for November 20, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected under a firm fixed-price contract structure with no set-aside designation. This delivery order represents one of numerous purchases issued to the...
- The Defense Logistics Agency awarded a $2,513.56 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Eylea 2 mg/0.05 ml vials. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 24, 2025, represents a specialized pharmaceutical procurement under DLA's broader pharmaceutical supply mission. This award carries no set-aside designation,...
- The Defense Logistics Agency awarded a $20,220 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA HD 8 mg/0.07 mL vials. The delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, contains no set-aside designation, indicating the award was made through competitive procurement. DMS Pharmaceutical Group Inc. will serve as the...
- The U.S. Defense Logistics Agency (DLA) awarded a $3,940.44 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, which has a completion date of July 18, 2024, is for the supply of EYLEA 2 MG/0.05 ML VIAL 0.05ML, a pharmaceutical product used to treat certain medical conditions. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to...
- The Defense Logistics Agency's Medical Supply Chain awarded a $3,666.90 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for EYLEA 2MG/0.05ML syringes. The award, issued on October 20, 2025, with an ultimate completion date of October 20, 2025, contains no set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group was...
- The U.S. Defense Logistics Agency (DLA), operating under the Medical Supply Chain, awarded a $29,335.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, issued July 7, 2025 with completion targeted for July 28, 2025, covers the supply of EYLEA 2 mg/0.05 mL syringes. This award was made without set-aside designation, leveraging the vendor's competitive positioning as a...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $6,283.85 by the Defense Logistics Agency on August 29, 2025, for the supply of EYLEA 2 mg/0.05 ml vials. The contract utilizes firm fixed-price pricing with an ultimate completion date of September 22, 2025, and carries no set-aside designation. This delivery order falls under DMS Pharmaceutical Group's larger single-award Indefinite...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB26FQAAQDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,513.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EYLEA 2 mg/0.05 ml vials. The award, issued on November 5, 2025, with an ultimate completion date of November 28, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (SPE2DR) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish multiple regional prime vendor contractors for recurring pharmaceutical supply needs across the Department of Defense. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial recent contracting activity demonstrating its capability to fulfill diverse and specialized pharmaceutical requirements for military healthcare facilities. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables. Under the PPV-G GEN V contract, which carries a ceiling value of $499,999,999 and extends through December 31, 2036, the Defense Logistics Agency maintains authority to issue delivery orders for pharmaceutical products to support Department of Defense healthcare operations globally, with DMS Pharmaceutical Group's established performance on numerous prior delivery orders validating its operational readiness.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.5k | 11/5/25 |